Risultati di ricerca
Identifying and characterizing high-risk populations in pilot malaria elimination districts in Madagascar: a mixed-methods study. In Madagascar, the districts of Antsirabe II, Faratsiho and Antsiranana I have relatively low malaria incidence rates and have been selected by the National Malaria Control Programme for pilot elimination stra...
5 giorni fa · A comprehensive review by the UN health agency has revealed critical gaps in understanding the full impact of climate change on malaria, dengue, trachoma and other tropical diseases. |.
5 giorni fa · Major infectious diseases. degree of risk: very high (2023) food or waterborne diseases: bacterial diarrhea, hepatitis A, and typhoid fever vectorborne diseases: malaria and dengue fever water contact diseases: schistosomiasis animal contact diseases: rabies note: on 31 August 2023, the US Centers for Disease Control and Prevention (CDC) issued a Travel Alert for polio in Africa; Madagascar is ...
2 giorni fa · Malaria is a mosquito-borne infectious disease that affects vertebrates. Human malaria causes symptoms that typically include fever, fatigue, vomiting, and headaches. In severe cases, it can cause jaundice, seizures, coma, or death. Symptoms usually begin 10 to 15 days after being bitten by an infected Anopheles mosquito.
5 giorni fa · New research flags the urgent need for research and evidence on the impact of climate change on neglected tropical diseases and malaria - World | ReliefWeb. World. New research flags the urgent...
5 giorni fa · BACKGROUND: In Madagascar, the districts of Antsirabe II, Faratsiho and Antsiranana I have relatively low malaria incidence rates and have been selected by the National Malaria Control Programme for pilot elimination strategies. The districts have residual transmission despite increasing coverage and quality of malaria services.
5 giorni fa · The RTS,S malaria vaccine was first recommended by WHO to prevent malaria in children in October 2021. The vaccine reached more than 2 million children in Ghana, Kenya and Malawi through the Malaria Vaccine Implementation Programme (MVIP) from 2019 to 2023.
